Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 01, 2017 16:15 ET | Source: Cytori Therapeutics

Cytori Announces Corporate Restructuring & Cost Reduction Plan

SAN DIEGO, Sept. 01, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ:CYTX) (“Cytori” or the “Company”) today announced a substantial corporate restructuring intended to significantly reduce...
August 10, 2017 16:25 ET | Source: Cytori Therapeutics

Cytori Reports Second Quarter 2017 Business and Financial Results

SAN DIEGO, Aug. 10, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ:CYTX) (“Cytori” or the “Company”) today announced its second quarter 2017 financial results and provided updates on its...
August 04, 2017 16:05 ET | Source: Cytori Therapeutics

Cytori to Webcast Second Quarter Financial Results on August 10

SAN DIEGO, Aug. 04, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) will provide a live webcast of its second quarter financial results and business update on Thursday, August 10,...
July 25, 2017 16:30 ET | Source: Cytori Therapeutics

Cytori Therapeutics Announces Inducement Grants for New Employees

SAN DIEGO, July 25, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) (the “Company”), announced today that the Compensation Committee of the Company's Board of Directors granted...
July 24, 2017 08:00 ET | Source: Cytori Therapeutics

Cytori Announces Top-Line 24- and 48-Week Results from the STAR Trial of Habeo™ Cell Therapy in Patients with Scleroderma

Statistical significance not achieved in primary or secondary efficacy endpointsClinically meaningful efficacy trends observed in primary and secondary endpoints in pre-specified diffuse cutaneous...
July 10, 2017 07:00 ET | Source: Cytori Therapeutics

American Medical Association Approves New Category III CPT Codes Describing Cytori’s Scleroderma Therapy

SAN DIEGO, July 10, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced today that the American Medical Association’s (AMA) CPT® (Current Procedural Terminology) Editorial...
July 06, 2017 07:00 ET | Source: Cytori Therapeutics

Cytori Receives Key Cell Therapy Patent for Scleroderma

Strengthens Global Scleroderma Intellectual Property Portfolio Extends E.U. protection through 2034 SAN DIEGO, July 06, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) (“Cytori”...
June 14, 2017 09:00 ET | Source: Cytori Therapeutics

Cytori® Partners with myTomorrows for Managed Access Program for Europe, Middle East and Latin America

SAN DIEGO, June 14, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) ("Cytori" or the "Company"), announces its new managed access program partnership with myTomorrows at the...
June 08, 2017 07:00 ET | Source: Cytori Therapeutics

Long Term Safety Data Published on Cytori Technology for Breast Reconstruction After Oncologic Surgery & Radiation Therapy

SAN DIEGO, June 08, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) (“Cytori” or the “Company”) today announced the publication of long-term follow-up data reporting patient...
June 01, 2017 07:00 ET | Source: Cytori Therapeutics

Cytori to Introduce Next-Generation Celution® Technology

SAN DIEGO, June 01, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) ("Cytori" or the "Company"), today announced plans to introduce its next-generation Celution® technology. ...